Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation.

MLA

Tajti, Gabor, et al. “Positive Correlation of Airway Resistance and Serum Asymmetric Dimethylarginine (ADMA) in Bronchial Asthma Patients Lacking Evidence for Systemic Inflammation.” Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, vol. 14, Jan. 2018, p. 2. EBSCOhost, https://doi.org/10.1186/s13223-017-0226-5.

APA

Tajti, G., Papp, C., Kardos, L., Keki, S., Pak, K., Szilasi, M. E., Gesztelyi, R., Mikaczo, A., Fodor, A., Szilasi, M., & Zsuga, J. (2018). Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation. Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 14, 2. https://doi.org/10.1186/s13223-017-0226-5

Chicago

Tajti, Gabor, Csaba Papp, Laszlo Kardos, Sandor Keki, Krisztian Pak, Magdolna Emma Szilasi, Rudolf Gesztelyi, et al. 2018. “Positive Correlation of Airway Resistance and Serum Asymmetric Dimethylarginine (ADMA) in Bronchial Asthma Patients Lacking Evidence for Systemic Inflammation.” Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology 14 (January): 2. doi:10.1186/s13223-017-0226-5.